Drugs Made In America Acquisition Corp.

DMAAR·NasdaqGM
Compare
0.0955−0.0234 (−19.68%)today
At close: Oct 22, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.1189
Open0.0955
Day range—
52-week range—
Off day high0.00%
Off 52-week high0.00%
Volume207
Avg. volume (3M)—
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding20.40M
Short interest—
Earnings dateMay 20, 2025
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
DMAAR APUS ANIP AMRX ACXP INM
Market cap — 4.77M 1.69B 7.13B 6.34M 7.31M
P/E (TTM) — — 16.0 41.0 — —
Forward P/E — — 7.3 17.0 -0.7 -0.2
Price/book -0.3 4.9 2.6 198.8 0.7 6.6
Dividend yield — — — — — —
1-year change — −81.26% −23.88% +93.86% −82.31% −33.00%
Today −19.68% −2.77% +2.09% +1.39% −0.87% −2.21%

The closest companies by business. Prices may be delayed up to 15 min.

Latest news

All DMAAR news ›

From articles in the 4Search news index.

In the news

3mentions in 30 days
3with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.